AI assistant
INTUITIVE SURGICAL INC — Director's Dealing 2025
Oct 30, 2025
29809_dirs_2025-10-29_ae6d4a91-2781-460c-8b33-7b63fbff1e2e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INTUITIVE SURGICAL INC (ISRG)
CIK: 0001035267
Period of Report: 2025-10-28
Reporting Person: Curet Myriam (EVP & Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-10-28 | Common Stock | M | 5030 | $242.3367 | Acquired | 5383 | Direct |
| 2025-10-28 | Common Stock | S | 5030 | $548.4254 | Disposed | 353 | Direct |
| 2025-10-28 | Common Stock | M | 1153 | $229.39 | Acquired | 1506 | Direct |
| 2025-10-28 | Common Stock | S | 1153 | $548.4254 | Disposed | 353 | Direct |
| 2025-10-28 | Common Stock | M | 1379 | $208.9 | Acquired | 1732 | Direct |
| 2025-10-28 | Common Stock | S | 1379 | $548.4254 | Disposed | 353 | Direct |
| 2025-10-29 | Common Stock | M | 125 | $208.9 | Acquired | 125 | Direct |
| 2025-10-29 | Common Stock | S | 125 | $543.0 | Disposed | 0 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-10-28 | Non-Qualified Stock Option (right to buy) | $208.9 | M | 1379 | Disposed | 2029-08-28 | Common Stock (1379) | Direct |
| 2025-10-29 | Non-Qualified Stock Option (right to buy) | $208.9 | M | 125 | Disposed | 2029-08-28 | Common Stock (125) | Direct |
| 2025-10-28 | Non-Qualified Stock Option (right to buy) | $229.39 | M | 1153 | Disposed | 2030-02-27 | Common Stock (1153) | Direct |
| 2025-10-28 | Non-Qualified Stock Option (right to buy) | $242.3367 | M | 5030 | Disposed | 2030-08-28 | Common Stock (5030) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 353 | Indirect |
Footnotes
F1: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on July 29, 2026.
F2: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $545.57 to $551.71 as follows: 1,173 shares sold at $545.57 to $546.54; 2,460 shares sold at $546.69 to $547.63; 314 shares sold at $547.72 to $548.68; 2,610 shares sold at $549.26 to $550.21; 1,000 shares sold at $550.39 to $551.04; 5 shares sold at $551.71. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.
F4: 12.5% of the shares subject to the option vest on the six-month anniversary measured from February 10, 2023, and 1/48th of the total number of shares vest in forty-two (42) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date.